Table 2.
Name (Number) P (Mechanism) a |
Compound’s Structure |
pKi | Ref. | Name (Number) P (Mechanism) a |
Compound’s Structure |
pKi | Ref. |
---|---|---|---|---|---|---|---|
Cathinone and its derivatives |
Naphyrone (13) FA |
4.96 | [34] | ||||
Cathinone (1) AG a |
6.00 | [34] |
MDPV (14) FA |
4.88 | [34] | ||
Flephedrone (2) AG |
6.00 | [34] |
Pyrovalerone (15) FA |
4.88 | [34] | ||
Mephedrone (3) AG |
5.68 | [34] |
MDPPP (16) FA |
4.20 | [21] | ||
Methcathinone (4) AG |
5.23 | [34] | Benzo[d][1,3]dioxole-based SCs | ||||
4-Bromomethcathinone (5) IA/FA |
5.20 | [21] |
MDBD (17) AG |
5.20 | [34] | ||
3-Bromomethcathinone (6) IA/FA |
5.00 | [21] |
MDMA (18) AG |
5.11 | [34] | ||
2-Fluoromethcathinone (7) IA/FA |
5.00 | [21] |
Butylone (19) AG |
4.88 | [34] | ||
2-(Trifluoromethoxy) -methcathinone (8) IA/FA |
5.00 | [21] |
Ethylone (20) AG |
4.88 | [34] | ||
Pyrovalerone-based SCs |
MDEA (21) AG |
4.88 |
MDEA
AG (21) |
||||
α-PPP (9) IA/FA |
5.60 | [21] |
Methylone (22) AG |
4.88 | [34] | ||
4-Methyl-α-PPP (10) IA/FA |
5.50 | [21] | SCs ’ precursors | ||||
4-Bromo-α-PPP (11) IA/FA |
5.40 | [21] |
Amphetamine (23) AG |
4.88 | [34] | ||
3-Bromo-α-PPP (12) IA/FA |
5.00 | [21] |
Methamphetamine (24) AG |
4.88 | [34] |
a Pharmacology: AG—agonist, IA—inverse agonist, PA—partial agonist, FA—full antagonist.